About Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention publishes original peer-reviewed, population-based research on cancer etiology, prevention, surveillance, and survivorship. The following topics are of special interest: descriptive, analytical, and molecular epidemiology; biomarkers including assay development, validation, and application; chemoprevention and other types of prevention research in the context of descriptive and observational studies; the role of behavioral factors in cancer etiology and prevention; survivorship studies; risk factors; implementation science and cancer care delivery; and the science of cancer health disparities. Besides welcoming manuscripts that address individual subjects in any of the relevant disciplines, CEBP editors encourage the submission of manuscripts with a transdisciplinary approach.
- Risk Factor Epidemiology
Submissions related to exposures and other factors associated with the risks of developing cancer, cancer mortality, and outcomes in cancer survivors including, but not limited to, family history, aging, environment, socioeconomics, diet, obesity, physical inactivity, smoking, and other behaviors, infections, chronic diseases, and use of medications for other indications.
- Genetic/Genomic & Molecular Epidemiology
Submissions that include epidemiologic studies, including consortia, that examine DNA-based or other molecular biomarkers, as well as ‘omics, in blood, urine, saliva or other bodily fluids, or in tissue, in relation to cancer risk or outcomes, or that describe the epidemiology of those DNA-based or other molecular markers.
- Biomarkers, -Omics & Systems Biology
Submissions related to the development of biomarkers, including ‘omics for future application in epidemiologic studies or future implementation in cancer prevention (e.g., risk stratification or screening), as well as studies describing new methods in relevant areas including the collection, storage, management, and distribution of biological samples and biospecimen science. Studies that focus solely on the development of a biomarker for clinical use in diagnosis, prognosis or treatment response and side effects are not of priority, unless epidemiological components (e.g., effect modification by age, sex) are rigorously applied or mechanistic information about carcinogenesis and/or risk is provided.
- Methods & Models
Submissions related to statistical methods or computational models in cancer research. The methods or models should be related to epidemiology; the use of biomarkers for measuring exposure or characterizing disease or precursor conditions; or cancer prevention.
- Nutrition & Energy Balance
Submissions on all aspects of nutrition and energy balance and human cancer, including population studies and experimental human feeding and exercise trials, as well as studies describing new methods in relevant areas.
- Screening & Early Detection
Submissions related to all aspects of the biology of screening and early detection of cancer in humans, as well as studies describing new methods in relevant areas.
- Behavioral & Intervention Research
Submissions that examine determinants of both risky and protective behaviors as well as interventions to promote risk-reducing behaviors, including smoking cessation and prevention; prevention-, screening and early-detection-associated behaviors; relevant interventions; policy studies; decision-making studies; quality-of-life studies; late effects of cancer treatment and survivorship; and studies describing new methods.
- Survivorship & Supportive Care
Submissions related to all aspects of both observational and interventional cancer survivorship in humans. Population studies, as well as studies describing new methods in relevant areas, are of particular interest.
- Cancer Health Disparities
Submissions that explore the determinants of differences in cancer prevalence, mortality, survivorship, and burden among specific population groups. Studies that examine outcomes of interventions to address disparities at individual, clinical, and community levels are also of interest
- Cancer Surveillance Research
Original reports using cancer case and population-based data to examine, test, and develop hypotheses for cancer incidence, mortality, and prevalence.
- Implementation Science & Cancer Care Delivery
Submissions focusing on research to improve the quality of cancer care by understanding and intervening on patient, clinician, and health system factors involved in care delivery, as well as studies examining the impact of cancer control and population science on the health and health care of the population, and fostering the rapid integration of research, practice, and policy, across the cancer continuum.
Cancer Epidemiology, Biomarkers & Prevention welcomes submission of original research and review articles to the journal. For descriptions and length requirements of the article types available to submitting authors, see the journal’s Categories of Articles.
The AACR Journals all use a similar Editorial Process and adhere to the same overarching Editorial Policies, both of which are detailed in the Instructions for Authors. These instructions contain important guidelines on authorship, publishing ethics, availability of materials and data, and data analysis and reporting. Authors should be familiar with these instructions prior to submitting their work to the journal.
Manuscripts are stringently reviewed for high standards of scientific merit, and only those articles that report results of novel, timely, and broadly significant research are accepted for publication.
For detailed metrics about Cancer Epidemiology, Biomarkers & Prevention and the other AACR journals see AACR Journals Metrics.
Editorial oversight of Cancer Epidemiology, Biomarkers & Prevention and decisions on manuscripts submitted to the journal are the responsibility of the Editorial Board with support from journal staff. See Editorial Board for more information.
Material published in Cancer Epidemiology, Biomarkers & Prevention is covered and protected by copyright. Authors who wish to publish articles and other material in AACR journals must formally transfer copyright to the AACR but are granted considerable reuse rights. The final typeset version of every published article is rendered freely accessible 12 months after publication. Authors who prefer for their article to be immediately freely accessible online may make this selection by paying an additional fee through the AACR AuthorChoice option. In addition, the AACR assists authors in satisfying major funder Open Access archiving mandates by depositing the accepted author version of their article in a designated public repository. For additional details about all these topics, see Copyright, Permissions and Access
To defray publication costs and to support other AACR programs, publication in Cancer Epidemiology, Biomarkers & Prevention involves the payment of a fixed publication fee and an additional fee for any color figures. If no financial support exists, authors may apply for a waiver of the fixed publication fee at the time of submission. See Publication Fees for further details.
Cancer Epidemiology, Biomarkers & Prevention (CEBP) (Print ISSN: 1055-9965: Online ISSN 1538-7755) is published monthly, one volume/year, by the American Association for Cancer Research, Inc. (AACR).
Cancer Epidemiology, Biomarkers & Prevention is abstracted and/or indexed in in BIOSIS Previews®, Current Contents/Clinical Medicine®, MEDLINE, Science Citation Index, Scopus, and Web of Science.
The journal is printed on paper that meets the requirements of ANSI/NISO Z39.48-1992 (Permanence of Paper).
Back Issues and Single Copy Sales
Subject to availability, single or back issues of Cancer Epidemiology, Biomarkers & Prevention may be purchased for $60 per copy in the U.S. or $65 per copy outside the U.S. For more information, contact:
AACR Publications Sales & Marketing Department
American Association for Cancer Research
615 Chestnut Street, 17th Floor
Philadelphia, PA 19106-4404
Phone: (215) 440-9300; or Toll Free: (855) 744-4667
Cancer Epidemiology, Biomarkers & Prevention Editorial Office
American Association for Cancer Research | Publications Division
615 Chestnut Street | 17th Floor | Philadelphia, PA 19106-4404
Phone: (215) 440-9300 | Fax: (215) 440-9337 | E-mail: email@example.com